🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Proud to have our CEO, Joana Simões Correia, participating in the EIC Women Leadership Programme Launching Event #EUeic

Exogenus Therapeutics announces a new research collaboration with Boehringer Ingelheim Ingelheim to explore the use of extracellular vesicles as therapeutic tools, focused on pre-clinical testing of its lead candidate Exo-101 in various regenerative medicine indications.

Happy International Women’s Day! Today we are celebrating gender equality and women’s achievements as part of the workforce. At ExogenusTherapeutics, we are proud to be led by a determined female leader and having a team with a strong female presence.

Great to see our CEO Joana Simões Correia recognized by Link To Leaders, explaining in her own (Portuguese) words the drive for launching Exogenus Therapeutics and starting this adventurous path that brought us here. linktoleaders.com/conheca-a-star…

Our CEO Joana Simões Correia is an invited speaker at the 3rd scientific conference of the Fundação para a Ciência e a Tecnologia (FCT)´s 25th Anniversary Celebration Program. Fell free to join us today! fct.pt/noticias/index…

We proud to welcome Tânia Lourenço to our scientific team. Tânia brings a strong background in pre-clinical research and standardized lab practices. Because translating knowledge isn’t all about science, Tânia is currently finishing her MBA...

Join our CEO and CSO, Joana Simões Correia at the 4th Exosome Based Therapeutic Development Summit, taking place in Boston, October 4th-6th, to learn more about extracellular vesicles and their translation to the biopharmaceutical market. lnkd.in/gYX7FSW6

We are excited to be one of the 18 startups selected to join the newest edition of the Blue Value Accelerator. At ExogenusTherapeutics, we believe that blue resources can become important sources of extracellular vesicles for healthcare. Meet the startups here: 👉 lnkd.in/dnYEa7UQ

ExogenusTherapeutics strengthens IP portfolio with patent granted in China and Korea. TO READ MORE CLICK HERE: 👇 👇 👇 👇 👇 lnkd.in/dHURbfh3 #ExogenusTherapeutics #exosomeresearch #extracellularvesicles #innovativehealthcare #Intellectualproperty #IPChina

Merck Ventures Innovation center opens its doors to #startups and #investors with Merck's Roel Bulthius's keynote on #investment strategies. #SMEInstrument #SMEIacceleration

We're Venture Lounge in Darmstadt today! Double portuguese representation alongside Sword Health. Best of luck to all!

What if there was a way for the chronic wounds to heal faster 🤕? Pitching their idea of a tool for the treatment of such wounds, up next is #SMEInstrument innovator ExogenusTherapeutics! #SMEIacceleration

And Exogenus is among one of the winners today! x.com/H2020SME/statu…

Last startup @ #StartupSlam: Exogenus targets skin lesions. Their platform tech uses exosomes secreted from umbilical cord #BIOEUROPE

And we won! #startups #BioEurope

Exogenus also dots the Portuguese Life Sciences map on Labiotech.eu x.com/EIPGeu/status/…

Not as good as getting the funding ourselves but not bad being mentioned alongside much bigger companies in exosomes! x.com/Xconomy/status…

🎥 Our very own @EBDKari speaks to Joana Simões Correia of ExogenusTherapeutics, winner of the #StartupSlam “best pitch” at #BIOEurope. Watch full interview >> bit.ly/2AZA1RC

Proud to be one of them! x.com/JNJInnovation/…

Presenting a poster at #ISEV2018 on "Development of a standardized exosome production process for clinical use". Exhibit Hall from 17:15.